Cardarine, or GW501516, is a blowtorch to Fat.. A PPAR that binds to receptors in skeletal muscle tissue and body fat and pushes skeletal muscle cells towards preferential lipid utilization and fat burning. It is often wrongly classified as a selective androgen receptor modulator (SARM). As a PPAR, it shares certain commonalities with SARMs but differs from them in a few important ways. GW 501516 does not affect androgen receptors or alter testosterone levels.
Invented in the early 1990s, Cardarine is also known by a number of alternate names, including GW1516 and GSK-516. It is known to provide a broad range of experimental effects, such as:
Increases fatty acid oxidation and promotes fat loss
Lower LDL cholesterol (“bad choleseterol”)
Higher HDL cholesterol (“good cholesterol”)
Decreases insulin resistance and improves glucose tolerance
Cardarine has not been approved by the FDA for human consumption and is for research purposes only.